NVO

$0.00

(

0.00%

)
Quote details

stock

Novo Nordisk A/S

NYSE | NVO

56.04

USD

$0.00

(

0.00%

)

At Close (As of Oct 16, 2025)

$257.85B

Market Cap

14.6

P/E Ratio

3.88

EPS

$115.87

52 Week High

$44.54

52 Week Low

HEALTHCARE

Sector

NVO Chart

Recent Chart
Price Action

NVO Technicals

Tags:

NVO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (DKK)
Gross Profit $246B
Total Revenue $290B
Cost Of Revenue $45B
Costof Goods And Services Sold $45B
Operating Income $128B
Selling General And Administrative $5.3B
Research And Development $48B
Operating Expenses $118B
Investment Income Net -
Net Interest Income -$91M
Interest Income $1.8B
Interest Expense $1.6B
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.5B
Income Before Tax $127B
Income Tax Expense $26B
Interest And Debt Expense -
Net Income From Continuing Operations $101B
Comprehensive Income Net Of Tax -
Ebit $129B
Ebitda $137B
Net Income $101B

Revenue & Profitability

Earnings Performance

NVO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (DKK)
Total Assets $466B
Total Current Assets $161B
Cash And Cash Equivalents At Carrying Value $16B
Cash And Short Term Investments $16B
Inventory $41B
Current Net Receivables $87B
Total Non Current Assets $305B
Property Plant Equipment $162B
Accumulated Depreciation Amortization Ppe -
Intangible Assets $91B
Intangible Assets Excluding Goodwill $91B
Goodwill $20B
Investments -
Long Term Investments $2.7B
Short Term Investments $11B
Other Current Assets $6.3B
Other Non Current Assets -
Total Liabilities $322B
Total Current Liabilities $218B
Current Accounts Payable $29B
Deferred Revenue -
Current Debt -
Short Term Debt $13B
Total Non Current Liabilities $105B
Capital Lease Obligations $6.8B
Long Term Debt $84B
Current Long Term Debt $12B
Long Term Debt Noncurrent -
Short Long Term Debt Total $103B
Other Current Liabilities $166B
Other Non Current Liabilities $23M
Total Shareholder Equity $143B
Treasury Stock -
Retained Earnings $144B
Common Stock $446M
Common Stock Shares Outstanding $4.5B

yearly Cash Flow (As of Dec 31, 2024)

Field Value (DKK)
Operating Cashflow $121B
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $8.5B
Capital Expenditures $51B
Change In Receivables -
Change In Inventory -$9B
Profit Loss -
Cashflow From Investment -$129B
Cashflow From Financing $8.7B
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $44B
Dividend Payout Common Stock $44B
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$20B
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $101B

yearly Income Statement (As of Dec 31, 2024)

Field Value (DKK)
Gross Profit $246B
Total Revenue $290B
Cost Of Revenue $45B
Costof Goods And Services Sold $45B
Operating Income $128B
Selling General And Administrative $5.3B
Research And Development $48B
Operating Expenses $118B
Investment Income Net -
Net Interest Income -$91M
Interest Income $1.8B
Interest Expense $1.6B
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.5B
Income Before Tax $127B
Income Tax Expense $26B
Interest And Debt Expense -
Net Income From Continuing Operations $101B
Comprehensive Income Net Of Tax -
Ebit $129B
Ebitda $137B
Net Income $101B

Dividends

Field Value
Ex Dividend Date 2025-08-18
Declaration Date 2025-08-06
Record Date 2025-08-18
Payment Date 2025-08-26
Amount 0.584816

NVO News

NVO Profile

Novo Nordisk A/S Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - GENERAL

Novo Nordisk A/S (NVO) is a premier global healthcare company headquartered in Bagsvaerd, Denmark, renowned for its expertise in diabetes care, obesity treatment, and hormone replacement therapies. The company stands at the forefront of innovation, utilizing advanced biotechnology and rigorous scientific research to develop and manufacture high-quality pharmaceutical products aimed at chronic disease management. As a leader in the biopharmaceutical sector, Novo Nordisk is dedicated to enhancing patient outcomes and promoting sustainability, while upholding a strong commitment to ethical business practices and corporate responsibility.

VHAI
-20.00%
$0.00
VIVK
+4.67%
$0.30
YYAI
-10.71%
$0.12
BURU
+2.88%
$0.34
NVDA
-0.11%
$179.83
RXRX
-7.21%
$6.29
EPWK
+16.29%
$0.08
CGBS
-39.47%
$0.03
IVF
+153.11%
$1.90
PLUG
-8.70%
$3.51
BITF
-15.68%
$5.45
ADAP
+6.57%
$0.19
YDKG
-54.14%
$0.08
NVTS
+2.73%
$15.57
BYND
-22.39%
$0.52
DNN
-2.83%
$3.08
RGTI
-12.76%
$49.15
NIO
-1.09%
$6.74
MIRA
+49.24%
$1.97
SCNX
-20.41%
$0.56
F
-0.27%
$11.72
BBD
+1.71%
$3.25
WHWK
+27.64%
$2.68
KVUE
-13.43%
$14.07
ACHR
-7.36%
$12.07
TLRY
-8.41%
$1.53
TSLA
+1.37%
$435.15
IONZ
+18.46%
$3.41
AXDX
-61.36%
$0.03
INTC
-1.10%
$36.74
DFLI
-32.52%
$1.32
CAN
-14.28%
$1.68
HPE
-10.09%
$22.51
ONDS
-15.03%
$8.07
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
GDXD
-7.91%
$0.61
ETHD
+4.23%
$3.94
RIG
-3.00%
$3.21
MARA
-11.62%
$20.18
CLF
-3.39%
$13.47
GNPX
-43.15%
$0.47
BTG
+3.96%
$5.89
FEMY
+33.89%
$0.73
LAES
-15.15%
$6.35
VSEE
-8.56%
$0.54
BTBT
-8.99%
$3.69
AAL
-6.00%
$11.75
ABAT
-21.00%
$8.94
LGCB
+35.15%
$2.23
QBTS
-10.47%
$40.08
NAK
-14.20%
$2.26
QS
-12.89%
$15.54
QSI
-3.23%
$2.54
RF
-5.98%
$23.26
CIFR
-10.48%
$18.82
RGTZ
+30.51%
$11.35
CRML
-13.96%
$19.54
UUUU
-12.80%
$21.79
QUBT
-12.12%
$18.65
MASK
+18.73%
$0.57
HBAN
-5.00%
$15.39
IREN
-8.94%
$61.89
SNAP
-2.46%
$7.71
RR
-6.38%
$5.76
CLSK
-13.92%
$19.97
RMBL
+60.50%
$3.21
GPUS
-6.53%
$0.36
PLTR
-0.74%
$178.28
ASST
-11.57%
$0.84
ADD
-25.47%
$0.05
WOK
+3.29%
$0.05
SOUN
-3.66%
$20.61
NOK
+0.53%
$5.68
AUUD
+3.41%
$2.12
WULF
-9.53%
$13.99
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
APLD
-1.69%
$37.11
NEHC
+9.12%
$3.35
PFE
-0.59%
$24.24
SRM
+53.27%
$10.30
SOND
+78.80%
$1.64
WTO
-88.69%
$0.13
SMR
-7.73%
$49.29
TOVX
-47.86%
$0.43
FNB
-8.00%
$14.52
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
SATL
-29.71%
$2.91
JBLU
-4.94%
$4.70
AMC
-2.12%
$2.76
AMZN
-0.81%
$213.82
HIMS
-6.07%
$58.94
BMNR
-4.71%
$51.26
ELWS
+48.09%
$5.45
GGB
-0.46%
$3.24
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
KEY
-6.45%
$16.58
VHAI
-20.00%
$0.00
VIVK
+4.67%
$0.30
YYAI
-10.71%
$0.12
BURU
+2.88%
$0.34
NVDA
-0.11%
$179.83
RXRX
-7.21%
$6.29
EPWK
+16.29%
$0.08
CGBS
-39.47%
$0.03
IVF
+153.11%
$1.90
PLUG
-8.70%
$3.51
BITF
-15.68%
$5.45
ADAP
+6.57%
$0.19
YDKG
-54.14%
$0.08
NVTS
+2.73%
$15.57
BYND
-22.39%
$0.52
DNN
-2.83%
$3.08
RGTI
-12.76%
$49.15
NIO
-1.09%
$6.74
MIRA
+49.24%
$1.97
SCNX
-20.41%
$0.56
F
-0.27%
$11.72
BBD
+1.71%
$3.25
WHWK
+27.64%
$2.68
KVUE
-13.43%
$14.07
ACHR
-7.36%
$12.07
TLRY
-8.41%
$1.53
TSLA
+1.37%
$435.15
IONZ
+18.46%
$3.41
AXDX
-61.36%
$0.03
INTC
-1.10%
$36.74
DFLI
-32.52%
$1.32
CAN
-14.28%
$1.68
HPE
-10.09%
$22.51
ONDS
-15.03%
$8.07
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
GDXD
-7.91%
$0.61
ETHD
+4.23%
$3.94
RIG
-3.00%
$3.21
MARA
-11.62%
$20.18
CLF
-3.39%
$13.47
GNPX
-43.15%
$0.47
BTG
+3.96%
$5.89
FEMY
+33.89%
$0.73
LAES
-15.15%
$6.35
VSEE
-8.56%
$0.54
BTBT
-8.99%
$3.69
AAL
-6.00%
$11.75
ABAT
-21.00%
$8.94
LGCB
+35.15%
$2.23
QBTS
-10.47%
$40.08
NAK
-14.20%
$2.26
QS
-12.89%
$15.54
QSI
-3.23%
$2.54
RF
-5.98%
$23.26
CIFR
-10.48%
$18.82
RGTZ
+30.51%
$11.35
CRML
-13.96%
$19.54
UUUU
-12.80%
$21.79
QUBT
-12.12%
$18.65
MASK
+18.73%
$0.57
HBAN
-5.00%
$15.39
IREN
-8.94%
$61.89
SNAP
-2.46%
$7.71
RR
-6.38%
$5.76
CLSK
-13.92%
$19.97
RMBL
+60.50%
$3.21
GPUS
-6.53%
$0.36
PLTR
-0.74%
$178.28
ASST
-11.57%
$0.84
ADD
-25.47%
$0.05
WOK
+3.29%
$0.05
SOUN
-3.66%
$20.61
NOK
+0.53%
$5.68
AUUD
+3.41%
$2.12
WULF
-9.53%
$13.99
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
APLD
-1.69%
$37.11
NEHC
+9.12%
$3.35
PFE
-0.59%
$24.24
SRM
+53.27%
$10.30
SOND
+78.80%
$1.64
WTO
-88.69%
$0.13
SMR
-7.73%
$49.29
TOVX
-47.86%
$0.43
FNB
-8.00%
$14.52
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
SATL
-29.71%
$2.91
JBLU
-4.94%
$4.70
AMC
-2.12%
$2.76
AMZN
-0.81%
$213.82
HIMS
-6.07%
$58.94
BMNR
-4.71%
$51.26
ELWS
+48.09%
$5.45
GGB
-0.46%
$3.24
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
KEY
-6.45%
$16.58

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.